Skip to main content
OpenTrials
Completed

NCT Number: NCT06964841

PRIMARY TESTICULAR LYMPHOMA

742 / 5.000 A 57-year-old male: Denies chronic degenerative, allergic, traumatic, transfusional, or surgical complications. He denies a family history of testicular cancer or abnormalities in testicular descent.

The patient presented with an enlarged right testicle that had been present for 1 month. He saw his family doctor, who prescribed antibiotic and analgesic treatment, without improvement, and was referred to our service. Upon examination, the right testicle was palpable, nontender, slightly enlarged, indurated, with nodulations measuring 0.5 cm in diameter, and free spermatozoa.

The left testicle was normal.

He underwent radical orchiectomy, which revealed renal testicular lymphoma.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

Male

Study type

Observational

Primary location

Instituto Mexicano del Seguro Social

Mérida, Yucatán, Mexico

About this study

A 57-year-old male: Denies chronic degenerative, allergic, traumatic, transfusional, or surgical complications. He denies a family history of testicular cancer or abnormalities in testicular descent.

The patient presented with an enlarged right testicle that had been present for 1 month. He saw his family doctor, who prescribed antibiotic and analgesic treatment, without improvement, and was referred to our service. Upon examination, the right testicle was palpable, non-tender, slightly enlarged, indurated, with nodulations measuring 0.5 cm in diameter, and free spermatozoa.

The left testicle was normal.

He underwent radical orchiectomy, which revealed renal-testicular lymphoma.

On the first postoperative day, the patient began to have stools with malignant cells and discontinuous invasion of the umbilical cord.

He was evaluated by the Gastroenterology department, who indicated the performance of an endoscopy, which revealed a 6 cm bleeding gastric ulcer. A biopsy was taken and a diffuse B-cell lymphoma was detected.

He was evaluated by the Gastroenterology department, who indicated the performance of an endoscopy, which revealed a large lesion.

On the first postoperative day, the patient began to have stools with malignant cells and discontinuous invasion of the umbilical cord.

He was evaluated by the Gastroenterology department, who indicated the performance of an endoscopy, which revealed a large lesion.

The patient continued to have melena and grade IV anemia. He was referred to pathology, where he was found to have OMS. He showed no improvement despite blood transfusions. He died. Immunohistochemistry for both testicular lesions and on the third postoperative day.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient with testicular lymphoma

Exclusion criteria

  • Patient without testicular lymphoma

Treatment and study plan

Primary outcomes

  1. Mortality

    Time frame: 3 months

    Describe the mortality in primary testicular lymphoma

Sponsors and collaborators

Lead sponsor

Instituto Mexicano del Seguro Social

Other Gov

Registry information

Official study title

PRIMARY TESTICULAR LYMPHOMA WITH EXTRA-NODAL STOMACH AFFECTATION

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
May 9, 2025
Registry last updated
May 9, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.